A Four-Year Institutional Experience of Immediate Lymphatic Reconstruction

Plastic and Reconstructive Surgery
Melisa D. Granoff1, Aaron Fleishman2, Kathy Shillue1, Anna Rose Johnson3, Jo‐Ellen Ross4, Bernard T. Lee5, Paige Teller6, Ted A. James4, Dhruv Singhal5
1Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
2Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
3Division of Plastic and Reconstructive Surgery, Washington University in St. Louis, St. Louis, MO, USA
4Department of Surgery
5Division of Plastic and Reconstructive Surgery,
6Division of Surgical Oncology, Maine Medical Center.

Tóm tắt

Introduction: Up to 1 in 3 patients may go on to develop breast cancer-related lymphedema (BCRL) after treatment. Immediate Lymphatic Reconstruction (ILR) is a surgical procedure that has been shown in early studies to reduce the risk of BCRL. However, long-term outcomes are limited due to its recent introduction and different institutions’ eligibility requirements. This study evaluates the incidence of BCRL in a cohort that underwent ILR over the long-term. Methods: A retrospective review of all patients referred for ILR at our institution from September 2016 through September 2020 was performed. Patients with preoperative measurements, a minimum 6-months follow-up data and at least one completed lymphovenous bypass were identified. Medical records were reviewed for demographics, cancer treatment data, intra-operative management and lymphedema incidence. Results: A total of 186 patients with unilateral node-positive breast cancer underwent axillary nodal surgery and attempt at ILR over the study period. Ninety patients underwent successful ILR and met all eligibility criteria, with a mean patient age of 54 (sd: 12.1) years and median BMI of 26.6 (q1-q3: 24.0-30.7) kg/m2. Median number of lymph nodes removed was 14 (q1-q3: 8-19). Median follow-up was 17 months (range: 6-49). 87% of patients underwent adjuvant radiotherapy of which 97% received regional lymph node radiation. At the end of the study period, we found an overall 9% rate of LE. Conclusion: Utilizing strict follow-up guidelines over the long-term, our findings support ILR at time of axillary lymph node dissection is an effective procedure that reduces the risk of BCRL in a high-risk patient population.

Từ khóa


Tài liệu tham khảo

Johnson, 2019, Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach., Ann Plast Surg, 82, S234, 10.1097/SAP.0000000000001864

Boccardo, 2009, Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy., Ann Surg Oncol, 16, 703, 10.1245/s10434-008-0270-y

Johnson, 2021, Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema., Plast Reconstr Surg, 147, 373e, 10.1097/PRS.0000000000007636

Cook, 2021, Immediate lymphatic reconstruction after axillary lymphadenectomy: a single-institution early experience., Ann Surg Oncol, 28, 1381, 10.1245/s10434-020-09104-2

Boccardo, 2014, Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up., Microsurgery, 34, 421, 10.1002/micr.22254

Brorson, 2012, Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment., J Plast Surg Hand Surg, 46, 410, 10.3109/2000656X.2012.714785

Runowicz, 2016, American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline., CA Cancer J Clin, 66, 43, 10.3322/caac.21319

2003, The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology., Lymphology, 36, 84

McDuff, 2019, Timing of lymphedema after treatment for breast cancer: when are patients most at risk?, Int J Radiat Oncol Biol Phys, 103, 62, 10.1016/j.ijrobp.2018.08.036

Thông tin
Thông tin xuất bản

Plastic and Reconstructive Surgery

Thông tin tác giả